|
| |
| Projects |
| The goal of the program is to provide students and researchers with a broad education in Computational Biology and Bioinformatics based on strong foundations in Computer Science, Biology and Mathematics. The curriculum includes practical experiences with experimental biology and computer science as cooperation and communication are key to success in this highly interdisciplinary field. The program should be open for qualified students all over the world. |
|
 |
 |
ARAVINDABIO is interested in problems in the area of Bioinformatics, in particular modeling and simulation of molecular sequence data. We like to work on problems close to the fundamentals, like sequence analysis and modeling of evolution,phylogenetic trees of species and especially some controversial and difficult phylogenies,etc. Currently the group is pursuing large-scale computational problems. |
|
| |
 |
COMPUTER AIDED DRUG DESIGNING (CADD)
|
| LIVE PROJECTS – BIOINFORMATICS / BIOTECHNOLOGY |
|
The area of the job openings in the Bioinformatics territory is the Drug Discovery (Computer aided) And Design. Many companies like Dr.Reddy’s, Cipla, Ranbaxy, Tcs, Wipro, Reliance life science, Matrix, suven lifescience, Jubilant Biosys, Orchid pharma, Lupin, GVK bio, Strand genomics, Biocon, HCL, Satyam, Sun Microsystems, IBM life science, Astrazenika, Novarties, Zydus cadila and many more ….are involved in Bioinformatics (Drug Design) projects.
Some of the latest advanced methods such as MM binding free energy calculations, FEP, Structure Based 3D QSAR, PHARMACOPHORE MODEL and ADME prediction are only having the huge demand (Job openings) in Bioinformatics Based Rational Drug design Research.
We, Aravinda bio, are the Only Expertise in latest Drug Design methods ( FEP, MM BINDING FREE ENERGY CALCULATIONS and PHARMACOPHORE MODEL, 3D QSAR,ADME) in Hyderabad.
We are offering the Real time industry relevant Rational Drug Designing (Bioinformatics & Cheminformatics) projects for the final year students, corporate professionals, PhD students and others.
|
|
| WE ARE APPLYING ABOVE JOB-ORIENTED METHODS IN THE FOLLOWING LIVE PROJECTS. |
 |
Tuberculosis |
|
AIDS |
|
Malaria |
|
Fungal infections |
|
Inflammation |
|
Eye disorders |
|
Alzheimer’s disease |
|
Growth hormone disorders |
|
Brain cancer |
|
Mental disorders |
|
Hair disorders |
|
Breast cancer |
|
Heart disorders |
|
Lung cancer |
|
Diabetics II |
|
Viral infections |
|
Parkinson’s disease |
|
& many more |
|
| |
| MINI PROJECTS ( DURATION OF PROJECT 2-3 WEEKS ) |
|
PROTEIN HOMOLOGY MODELING. |
|
SEQUENCE ANALYSIS FOR HUMAN DISEASE TARGETS. |
|
STRUCTURE ANALYSIS FOR HUMAN DISEASE TARGETS. |
|
PHYLOGENETIC ANALYSIS FOR HUMAN DISEASE TARGETS. |
|
STUDY AND ANALYSIS OF VARIABLE REGION OF HUMAN IMMUNOGLOBULIN. |
|
STUDY AND ANALYSIS OF HUMAN IG USING MOLECULAR PHYLOGENY |
|
COMPOSITIONAL AND STRUCTURAL ANALYSIS OF HUMAN IMMUNOGLOBULINS |
|
COMPOSITIONAL AND STRUCTURAL ANALYSIS OF MOUSE IMMUNOGLOBULINS |
|
COMPO AND STRUCTURAL ANALYSIS OF HUMAN IG RELATED TO BRAIN TUMOR |
|
COMPO AND STRUCTURAL ANALYSIS OF HUMAN IG FOR INFLUENZA VIRUS |
|
GENE BASED DRUG (INHIBITOR) DISCOVERY |
|
STRUCTURAL ANALYSIS OF PROTEIN TARGETS |
|
MICRO ARRAY GENE EXPRESSION ANALYSIS |
|
CLASSIFICATION AND PHYLOGENETIC ANALYSIS OF PROTEIN SEQUENCES |
|
DEVELOPMENT OF ORF FINDING TOOL BY USING PERL |
|
DEVELOPMENT OF ORF FINDER AND PROTEIN ANALYSIS TOOL BY USING PERL |
|
ANALYSIS OF ACUTE LYMPHOBLASTIC LEUKEMIA USING BIOINFO TOOLS |
|
COMPARATIVE MOLECULAR DYNAMICS SIMULATIONS OF VARIOUS DRUGS |
|
MOLECULAR DOCKING STUDIES OF VARIOUS PROTEIN TARGETS AND DRUGS |
|
NEW DRUG DESIGN FOR ALZHEMIER’S DISEASE |
|
NEW DRUG DESIGN FOR BRAIN CANCER. |
|
NEW DRUG DESIGN FOR TUBERCULOSIS |
|
NEW DRUG DESIGN FOR LUNG CANCER |
|
NEW DRUG DESIGN FOR HEART DISORDERS. |
|
NEW DRUG DESIGN FOR INSULIN DISORDERS |
|
NEW DRUG DESIGN FOR INFLAMMATION |
|
NEW DRUG DESIGN FOR ARTHRITIS |
|
NEW DRUG DESIGN FOR PARKINSONS’S DISEASE |
|
NEW DRUG DESIGN FOR BREAST CANCERS |
|
NEW DRUG DESIGN FOR EYE DISORDERS |
|
QSAR ANALYSIS FOR VARIOUS DRUGS |
|
MOLECULAR MODELING STUDIES OF VARIOUS DRUGS |
|
DISEASE TARGET VALIDATION FOR ALL CANCER DISEASES |
|
TARGET IDENTIFICATION AND VALIDATION FOR CARDIOVASCULAR DISORDERS |
|
COMAPRISON OF VARIOUS DOCKING SCORES |
|
BINDING FREE ENERGY CALCULATIONS FOR VARIOUS DISEASE AND DRUGS |
|
INTEGRATION STUDY OF ALL BIOINFORMATICS TOOLS |
|
HYDROGEN BOND INTERACTION STUDIES OF DRUGS WITH PROTEIN |
|
LIGAND BASED DRUG DISCOVERY & DESIGN FOR VARIOUS DISEASE |
|
COMPARISION OF KINETIC ENERGY IN TWO DIFFERENT SYSTEMS (SOLVENT AND GAS) |
|
NEW DRUG DESIGN FOR NONINSULIN-DEPENDENT DIABETES MELLITUS AND DIABETIC NEPHROPATHY |
|
ANALYSIS OF TARGET MOLECULE FOR DISEASE & IDENTIFYING DRUG CANDIDATE BY USING IN SILICO TOOLS. |
|
STRUCTURE BASED DRUG DISCOVERY& DESIGN FOR PARKINSON’S DISEASE |
|
RECEPTOR BASED DRUG DISCOVERY& DESIGN FOR ALZHIEMER'S DISEASE |
|
|
| MAJOR PROJECTS |
|
PROJECT-1)
ANALYSIS OF BETA AMYLOID AS A TARGET MOLECULE FOR ALZHEIMER’S DISEASE AND IDENTIFYING A DRUG CANDIDATE BY USING IN SILICO TOOLS. |
|
PROJECT-2)
ANALYSIS AND IDETIFICATION OF AMP4 AS A TARGET MOLECULE FOR EPILEPSY AND FINDING A DRUG CANDIDATE BY USING IN SILICO TOOLS. |
|
PROJECT-3)
STUDY AND ANALYSIS OF HUMAN IMMUNO GLOBULINS USING PERL & BIOINFORMATICS TOOLS. |
|
PROJECT-4)
COMPOSITIONAL AND STRUCTURAL ANALYSIS OF HUMAN IG RELATED TO BRAIN TUMOR. |
|
PROJECT-5)
COMPOSITIONAL AND STRUCTURAL ANALYSIS OF VARIABLE REGIONS OF HUMAN IG FOR INFLUENZA VIRUS. |
|
PROJECT-6)
STUDY AND ANALYSIS OF HUMAN IMMUNOGLOBULINS USING MOLECULAR PHYLOGENY. |
|
PROJECT-7)
STUDY AND ANALYSIS OF VARIABLE REGION OF HUMAN IMMUNOGLOBULINS USING ADVANCED BIOINFORMATICS TOOLS. |
|
PROJECT-8)
GENE BASED DRUG (INHIBITOR) DISCOVERY. |
|
PROJECT-9)
CLASSIFICATIONS AND PHYLOGENETIC ANALYSIS OF PROTEIN SEQUENCES. |
|
PROJECT-10)
GENE FEATURE DETECTION & GENE PREDICTION. |
|
PROJECT-11)
MICRO ARRAY GENE EXPRESSION ANALYSIS. |
|
PROJECT-12)
DEVELOPMENT OF ORF FINDER AND PROTEIN ANALYSIS TOOL BY USING PERL. |
|
PROJECT-13)
STUDY AND ANALYSIS OF HUMAN IMMUNOGLOBULINS USING MOLECULAR PHYLOGENY, PERL PROGRAMMING AND BIOINFORMATICS TOOLS. |
|
PROJECT-14)
ANALYSIS OF ACUTE LYMPHOBLASTIC LEUKEMIA USING PERL AND BIOINFORMATICS TOOLS. |
|
PROJECT-15)
COMPOSITIONAL ANALYSIS OF MOUSE IMMUNOGLOBULINS USING PERL AND ADVANCED BIOINFORMATICS TOOLS. |
|
PROJECT-16)
LIGAND BASED DRUG DISCOVERY & DESIGN FOR BRAIN CANCER. |
|
PROJECT-17)
DISEASE TARGETS IDENTIFICATION AND VALIDATION FOR BREAST CANCER & OVARIAN CANCER. |
|
PROJECT-18)
STRUCTURE BASED DRUG DISCOVERY& DESIGN FOR PARKINSON’S DISEASE. |
|
PROJECT-19)
RECEPTOR BASED DRUG DISCOVERY& DESIGN FOR ALZHIEMER'S DISEASE. |
|
PROJECT-20)
QSAR ANALYSES FOR HEPATITIS-C INHIBITORS DATABASE SCREENING. |
|
PROJECT-21)
HYDROGEN BOND INTERACTION STUDIES OF PENTOSTATIN AND CLADRIBINE DRUGS WITH ADENOSINE DEAMINASE PROTEIN. |
|
PROJECT-22)
MOLECULAR DOCKING STUDIES FOR VITMIN-D ANALOGS & ANTI INFLAMMATORY DRUGS. |
|
PROJECT-23)
SEQUENCE ANALYSIS & PROTEIN HOMOLOGY MODELING. |
|
PROJECT-24)
COMPARATIVE ANALYSIS OF VARIOUS DOCKING SCORES: A CASE STUDY OF ANTI TUMOR AND ANTI GLAUCOMA DRUGS. |
|
PROJECT-25)
ANTI- INFLAMMATORY DRUGS (CELECOXIB, ASPIRIN, FLURBIPROFEN) WITH SOLVENT (H2O) INTERACTION STUDIES. |
|
PROJECT-26)
COMPARISION OF KINETIC ENERGY IN TWO DIFFERENT SYSTEMS (SOLVENT AND GAS). |
|
PROJECT-27)
NEW DRUG DESIGN FOR NONINSULIN-DEPENDENT DIABETES MELLITUS AND DIABETIC NEPHROPATHY. |
|
PROJECT-28)
COMPARISON THE RESULTS OF VARIOUS DOCKING SOFTWARES; A CASE STUDY OF MATRIX METALLOPROTEINASE INHIBITORS. |
|
PROJECT-29)
MOLECULAR DYNAMICS SIMULATIONS FOR COX-2 INHIBITORS. |
|
PROJECT-30)
CONFORMATIONAL ANALYSIS FOR PROPRANOLOL ANALOGS. |
|
PROJECT-31)
NEW DRUG DEVELOPMENT FOR LUNG CANCER. |
|
PROJECT-32)
TARGET IDENTIFICATION AND VALIDATION FOR HEART DISORDERS. |
|
PROJECT-33)
A COMPARITIVE STUDY OF HISTAMINE RECEPTOR-2 INHIBITORS (BETAZOLE, RANITIDINE AND CIMETIDINE) FOR PEPTIC ULCER. |
|
PROJECT-34)
ASPRIN AND CELECOXIB ANALOGS DESIGN FOR NEW COX-2 INHIBITORS. |
|
|
PUBLICATIONS ORIENTED PROJECTS
TOPICS FOR PUBLICATION AND RESEARCH PROJECT:
|
|
QSAR STUDIES: |
- |
2D QSAR |
| |
|
- |
3D QSAR |
| |
|
|
|
|
ADMET |
- |
ADME and Toxicity Predictions |
| |
|
|
|
|
DOCKING |
- |
Novel Ligands |
| |
|
- |
Synthetic Ligands (Published) |
| |
|
- |
Natural Compound (Blind Docking) |
| |
|
- |
Comparative Docking (Various Targets) |
| |
|
- |
Comparative Docking (Various Ligands) |
|
MOLECULAR DOCKING & QSAR STUDIES |
- |
Molecular Docking and 3D QSAR for Published Ligands |
| |
|
- |
Published/ Designed: Comparative Analysis of Docking Studies |
| |
|
|
|
|
HOMOLOGY MODELING & DOCKING STUDIES. |
|
|
|
| |
| ONLINE PROJECTS |
|
All the topics as covered in Mini and Major project |
|
|
| ARAVINDA BIOSOLUTIONS TRAINING ELIGIBILITY |
|
Graduates and Postgraduates with specialization in any of the areas of molecular biology, genetics, microbiology, structural biology, chemistry and biotechnology (BSc , Btech, ME/M.Tech Etc..) |
|
Graduates and Postgraduates with specialization in any of the areas of Pharmacy (B.Pharm, M.Pharm, etc.) |
|
MCA, MSc (Maths, Stats) Software Professionals etc. |
|
PhDs in any science discipline |
|
| |
| WHY SHOULD YOU OPT THIS COURSE ? |
|
Bioinformatics, the application of informatics to biological problems, is used extensively to examine the structure function of genes and genes and proteins. |
|
The bioinformatics market primarily is driven by the need of pharmaceutical and biotechnology companies to increase the efficiency of their drug discovery and development efforts.
|
|
Biotech and Pharmaceutical companies use bioinformatics to identify drug targets and drug candidates, decreasing the time to bring new therapeutics to market.
|
|
The objective of this course is to impart training in software application development, mathematics, statistics, cell & molecular biology, and other bioinformatics tools like SAS (Statistical Analytical System).
|
|
Emphasis would be laid on understanding scientific databases & algorithms, sequence analysis and programming in various languages applicable to modern biology. |
|
The course includes an integrated project which involves the application of the above aspects. |
|
This course is designed to address the growing need of manpower for the biotech and pharmaceutical organizations. |
|
|
| CERTIFICATION |
|
Certificates will be provided from ARAVINDA BIOSOLUTIONS in association with Integrated Institute of Education Technology (IIET), an ISO 9001-2000 accredited institute (approved by Human Resource Department), Govt. of India. |
|
| |
| FACILITIES |
|
Full Fledged Computer Lab with Internet Facility |
|
Free Course Material |
|
Placement Assistance |
|
Affordable Fee Structure |
|
| |
| ELIGIBILITY |
|
Graduates and Postgraduates with specialization in any of the areas of bioinformatics, molecular biology, genetics, microbiology, structural biology, chemistry and biotechnology (BSc , BE/B.Tech, ME/M.Tech Etc..) |
|
Graduates and Postgraduates with specialization in any of the areas of Pharmacy (B.Pharm, M.Pharm, etc.) |
|
Research scholars/PhDs in any Life science discipline |
|
|
| SAILIENT FEATURES |
|
Experienced Faculty Members |
|
Guest faculties from reputed universities/organization will be arranged |
|
Limited students in each batch |
|
Certification tie-ups with Government approved Organizations with ISO certified. |
|
Certificates registered in all employment exchanges and Foreign embassy’s. |
|
Certificates registered in all employment exchanges and Foreign embassy’s. |
|
Full-fledged lab with high configured Systems. |
|
Placement assistance for deserving candidates |
|
Free Course Material |
|
|
| |
|
|
Home / Projects
